Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction - AIDA STEMI

Description:

The goal of the trial was to evaluate treatment with intracoronary bolus administration of abciximab compared with intravenous bolus administration among patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI).